Full Circle Healthcare: The Lingering Concerns and Challenges Left in COVID’s Wake

As vaccinations become the dominant part of the pandemic conversation and life reaches a new normal, what are the lingering challenges of those patients who suffered the effects of COVID-19, and what other concerns will exist?

David Macfarlane, the Marketing Communications Manager for Medsphere, shared his thoughts with host James Kent on what he believed some of those challenges might be in the months, and possibly years, to come.

From Macfarlane’s perspective, there are many primary concerns once the pandemic starts to get into a manageable shape. “At the top of that list has got to be the challenge of long COVID,” Macfarlane said. “We’ve got a number of people for whom this disease is something that they’re going to have to be managing for weeks, and perhaps months, after it looks as though they are out of the woods.”

Is the healthcare system prepared for long-term health issues related to COVID-19? Macfarlane said it is something healthcare is starting to discuss. “I don’t know that the healthcare system is geared to deal with the number of people who might need long-term care, because it could be a significant number,” Macfarlane said.

With so many unknowns, having sharable information and data related to COVID-19 patients makes EHR (electronic health records) such a potentially valuable healthcare resource. “As EHR’s have evolved, it’s become clear that one of their biggest benefits is the use of big data,” Macfarlane said. These vast data sets allow healthcare resources to scan for similarities in patient backgrounds, symptoms, and how bodies react to the symptoms and response to certain medicines.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More